# HANGZHOU Solution in Bicuspid AS Undergoing TAVR

> **NCT04722796** · NA · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 508 (estimated)

## Conditions studied

- Aortic Stenosis
- Aortic Stenosis With Bicuspid Valve

## Interventions

- **DEVICE:** TAVR with Venus A plus using supra-annular sizing and THV implantation technique (Hangzhou solution)
- **DEVICE:** TAVR with Venus A plus using annular sizing and THV implantation technique

## Key facts

- **NCT ID:** NCT04722796
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-12
- **Primary completion:** 2024-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 508 (ESTIMATED)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04722796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04722796, "HANGZHOU Solution in Bicuspid AS Undergoing TAVR". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04722796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*